Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Dick's Sporting Goods
DKS
$18.3B
| $34.8M | 0.01% |
175,909
-220,920
| -56% | -$48.2M |
|
|
CRWV
952
PUT
CoreWeave
CRWV
$48.7B
| $34.8M | 0.01% |
486,200
-619,600
| -56% | -$62.8M |
|
953
Bunge Global
BG
$21.5B
| $34.8M | 0.01% |
390,744
-71,781
| -16% | -$6.62M |
|
954
Vanguard S&P 500 ETF
VOO
$1.03T
| $34.8M | 0.01% |
55,447
-388,118
| -87% | -$241M |
|
955
Robert Half
RHI
$4.33B
| $34.5M | 0.01% |
1,271,833
+543,517
| +75% | +$15.5M |
|
956
iRhythm Holdings
IRTC
$4.04B
| $34.4M | 0.01% |
193,975
+7,222
| +4% | +$1.28M |
|
957
PUT
Prologis
PLD
$133B
| $34.4M | 0.01% |
269,600
| – | – |
|
958
Markel Group
MKL
$22.9B
| $34.4M | 0.01% |
15,985
-3,106
| -16% | -$6.29M |
|
959
Guardant Health
GH
$22.4B
| $34.3M | 0.01% |
336,274
+58,838
| +21% | +$5.26M |
|
960
PUT
Boyd Gaming
BYD
$6.03B
| $34.1M | 0.01% |
400,000
| – | – |
|
961
H&R Block
HRB
$5.86B
| $34.1M | 0.01% |
781,697
+22,726
| +3% | +$1.06M |
|
962
CALL
KraneShares CSI China Internet ETF
KWEB
$5.58B
| $34M | 0.01% |
1,000,000
+700,000
| +233% | +$26.9M |
|
963
CALL
VanEck Gold Miners ETF
GDX
$27.4B
| $34M | 0.01% |
396,400
-1,231,200
| -76% | -$97.3M |
|
964
BorgWarner
BWA
$14.1B
| $33.8M | 0.01% |
750,367
+521,733
| +228% | +$22.9M |
|
965
Rocket Lab Corp
RKLB
$48.8B
| $33.7M | 0.01% |
482,943
-41,325
| -8% | -$2.37M |
|
966
Stantec
STN
$8.53B
| $33.7M | 0.01% |
356,998
+229,698
| +180% | +$23.7M |
|
967
CALL
ConocoPhillips
COP
$151B
| $33.6M | 0.01% |
359,300
+340,000
| +1,762% | +$30.8M |
|
968
Woodward
WWD
$21.1B
| $33.6M | 0.01% |
111,111
-163,513
| -60% | -$45M |
|
969
Booz Allen Hamilton
BAH
$9.39B
| $33.5M | 0.01% |
397,498
+67,811
| +21% | +$6.07M |
|
970
Annaly Capital Management
NLY
$17.4B
| $33.5M | 0.01% |
1,498,845
-599,477
| -29% | -$13.1M |
|
971
nVent Electric
NVT
$27B
| $33.3M | 0.01% |
326,968
-138,060
| -30% | -$14.3M |
|
972
CALL
Ulta Beauty
ULTA
$23.4B
| $33.3M | 0.01% |
55,100
| – | – |
|
|
973
Boyd Gaming
BYD
$6.03B
| $33.2M | 0.01% |
389,662
+169,499
| +77% | +$14M |
|
|
ETHA
974
PUT
iShares Ethereum Trust ETF
ETHA
$5.49B
| $33.2M | 0.01% |
1,478,500
+1,196,500
| +424% | +$31.3M |
|
975
PUT
Rockwell Automation
ROK
$49.4B
| $32.9M | 0.01% |
+84,500
| New | +$31.8M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.